What can we conclude from the randomized controlled trials of fecal occult blood test screening?

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 3, 1998, Pages 199-204

  Lang, Christopher A ^b   Ransohoff, David F ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NONE

Author keywords

Colorectal cancer; Fecal occult blood test screening; Randomized controlled trials

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; META ANALYSIS; METHODOLOGY; OCCULT BLOOD; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0031924267     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199803000-00002     Document Type: Review

References (22)

1. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348:1472-1477.
2. Kronborg O, Fenger A, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348:1467-1471.
3. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al., for the Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328:1365-1371.
4. Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med 1979; 301:1410-1412.
5. Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336:542-545.
6. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: is mortality reduced by chance selection for screening colonoscopy? JAMA 1994; 271:1011-1013.
7. Ransohoff DF, Lang CA. Small adenomas detected during fecal occult blood screening for colorectal cancer: the impact of serendipity. JAMA 1990; 264:76-78.
8. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. Ca Cancer J Clin 1996; 65:5-27.
9. Lang CA, Ransohoff DF. Defining risk for colorectal cancer. In: Young G, Levin B, Rozen P, editors. Prevention and early detection of colorectal cancer: principles and practice. London: Saunders, 1996: 155-170.
10. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med 1997; 126:811-822.
11. Wagner JL, Tunis S, Brown M, et al. The cost effectiveness of colorectal cancer screening in average-risk adults. In: Young G, Levin B, Rozen P, editors. Prevention and early detection of colorectal cancer: principles and practice. London: Saunders, 1996:321-356. A clearly described and clearly documented cost-effectiveness analysis of this problem. Background documentation and copies of the model's program, implemented on a Lotus spreadsheet, are available from the authors.
12. Eddy DM. Screening for colorectal cancer. In preparation 1997.
13. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990; 113:373-384.
14. American College of Physicians. Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. Ann Intern Med 1997; 126:808-810.
15. Ransohoff DF, Lang CA. Sigmoidoscopic screening in the 1990s. JAMA 1993; 269:1278-1281.
16. Allison JE, Tekawa IS, Ransom U, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334:155-159.
17. Ransohoff DF, Lang CA. Improving the fecal occult-blood test. N Engl J Med 1996; 334:189-190 [editorial].
18. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. Improving the fecal occult-blood test [letter]. N Engl J Med 1996; 334:1607-1608.
19. Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James PD. et al. Randomized, controlled trial of faecal occult blood screening for colorectal cancer: results for first 107,349 subjects. Lancet 1989; 1:1160-1164.
20. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer: a controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1988; 62:645-651.
21. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing; results for 68,308 subjects. Scand J Gastroenterol 1994; 29:468-473.
22. Kronborg O. Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1989; 24:599-606.